98 related articles for article (PubMed ID: 7543953)
21. A pilot study of priming with granulocyte macrophage colony-stimulating factor plus all-trans retinoic acid combined with remission induction chemotherapy in patients with acute myeloid leukemia.
Shin HJ; Chung JS; Choi YJ; Cho GJ
Am J Clin Oncol; 2009 Jun; 32(3):227-32. PubMed ID: 19433969
[TBL] [Abstract][Full Text] [Related]
22. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
23. Treatment of acute promyelocytic leukaemia.
Fenaux P; Chomienne C; Degos L
Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
[TBL] [Abstract][Full Text] [Related]
24. Administration of granulocyte colony-stimulating factor during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia.
Usuki K; Nishizawa Y; Endo M; Osawa M; Kitazume K; Iki S; Watanabe M; Urabe A
Int J Hematol; 1996 Oct; 64(3-4):213-9. PubMed ID: 8923783
[TBL] [Abstract][Full Text] [Related]
25. [G-CSF and all-trans retinoic acid-induced leukocytosis].
Wu W; Sun G; Wu W
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):273-5. PubMed ID: 9387319
[TBL] [Abstract][Full Text] [Related]
26. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
Montillo M; Ricci F; Tedeschi A; Cafro AM; Nosari AM; Nichelatti M; Marbello L; Morra E
Leuk Res; 2009 Aug; 33(8):1072-8. PubMed ID: 19187960
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
Castaigne S; Degos L
C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience].
Sun GL
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122
[TBL] [Abstract][Full Text] [Related]
30. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
[TBL] [Abstract][Full Text] [Related]
31. [A "retinoic acid syndrome" observed in two cases of acute promyelocytic leukemia].
Horikoshi A; Sawada S; Aiso M; Kawamura M; Iizuka Y; Takeuchi J; Ohshima T; Horie T; Naoe T; Ohno R
Rinsho Ketsueki; 1993 Sep; 34(9):1044-9. PubMed ID: 8230749
[TBL] [Abstract][Full Text] [Related]
32. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
33. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
Wang ZY; Chen Z; Huang W; Li XS; Lu JX; Huang LA; Zhang FQ; Gu LJ; Ouyang RR; Chen SJ
Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
[TBL] [Abstract][Full Text] [Related]
34. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Al Bahar S; Pandita R; Bavishi K; Kreze O
Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Chen GQ; Shen ZX; Wu F; Han JY; Miao JM; Zhong HJ; Li XS; Zhao JQ; Zhu J; Fang ZW; Chen SJ; Chen Z; Wang ZY
Leukemia; 1996 May; 10(5):825-8. PubMed ID: 8656678
[TBL] [Abstract][Full Text] [Related]
36. The combined effects of all-trans retinoic acid and granulocyte colony-stimulating factor as a differentiation induction therapy for acute promyelocytic leukemia.
Tsurumi H; Tojo A; Takahashi T; Moriwaki H; Asano S; Muto Y
Intern Med; 1993 Aug; 32(8):648-50. PubMed ID: 7508772
[TBL] [Abstract][Full Text] [Related]
37. Prediction of growth sensitivity of acute promyelocytic leukemia cells to granulocyte colony-stimulating factor using 7AAD/PY during administration of all-trans retinoic acid.
Toba K; Koike T; Wang Y; Nagai K; Takahashi H; Hashimoto S; Uesugi Y; Aizawa Y
Int J Hematol; 1997 Aug; 66(2):203-12. PubMed ID: 9277051
[TBL] [Abstract][Full Text] [Related]
38. Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor.
Jansen JH; de Ridder MC; Geertsma WM; Erpelinck CA; van Lom K; Smit EM; Slater R; vd Reijden BA; de Greef GE; Sonneveld P; Löwenberg B
Blood; 1999 Jul; 94(1):39-45. PubMed ID: 10381496
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells.
Gianní M; Terao M; Zanotta S; Barbui T; Rambaldi A; Garattini E
Blood; 1994 Apr; 83(7):1909-21. PubMed ID: 7511442
[TBL] [Abstract][Full Text] [Related]
40. Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy.
Agadir A; Cornic M; Lefebvre P; Gourmel B; Balitrand N; Degos L; Chomienne C
Leukemia; 1995 Jan; 9(1):139-45. PubMed ID: 7845008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
